SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " ej " 3,741 found 🔀 AI-powered Shuffle
Vallejo: Armed Suspect Arrested After Allegedly Making Death Threats At Business
Police have arrested a man after he allegedly brandished a gun and made death threats to customers at a business in Vallejo, police said Sunday.
Polish scientists compare five kombuchas, and the tea in each changes far more than flavor
"The most surprising aspect was the scale of changes occurring during fermentation."
Prediction market Kalshi sues Illinois over its push to regulate sports bets
The most recent move in the ongoing legal battle between the state and prediction market operators came after the state enacted new sports wagering taxes to support the $55.9 billion budget it passed this spring.
Laredo Public Health issues summer food, pool safety reminders
Laredo Public Health is reminding residents of food and pool safety steps as warmer weather increases the risk of foodborne illness.
Buccaneers place two offensive leaders on CBS Sports Top 100 list
Tristan Wirfs and Baker Mayfield represented the Buccaneers on Pete Prisco’s CBS Sports Top 100 players list, highlighting Tampa Bay’s offensive core.
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
How Ron Harper Jr. Can Impact Boston Celtics Moving Forward
The New Jersey native is set to get a new deal from the C's.
Rep. Ryan rejects rolling back of PFAS cleanup at Stewart air base
Pat Ryan, a Democrat who represents New York’s 18th Congressional District, says the Department of Defense is looking to reduce statutory reporting requirements for PFAS at military installations.
Lyles to take charge of Ultimate Championship entertainment
Noah Lyles has been announced as an Ultimate Star for the World Athletics Ultimate Championship, taking place from September 11-13 in Budapest, Hungary.Lyles, the dominant US sprinter who has won consecutive 200m golds at the past four World Championships, is locked in to compete at the inaugural edition of the new global championship. Lyles has earned automatic qualification into both the 100m and 200m by virtue of his podium-topping performances in those disciplines at the Paris 2024 Olympic Games and the World Athletics Championships Tokyo 25, respectively.
Opinion | Trump’s Science Cuts Betray America’s Past Since Lewis and Clark
America has funded scientific research since 1804 — and remembers that first project as a national glory. Cutting similar funding today is a betrayal.
Tuchel 'following Germany' but 'heart with the English team'
Thomas Tuchel wants to refrain from offering advice to the Germany national team during the World Cup while he works as England coach. "Of course I'm following the German team.
Comer rejects calls for White House officials' Epstein testimony
Comer chairs the committee, which has been reviewing the federal government’s Epstein investigation.
Comer rejects calls for White House officials' Epstein testimony
Comer chairs the committee, which has been reviewing the federal government’s Epstein investigation.
Courteney Cox and Snow Patrol's Johnny McDaid separate after over 10 years together
Courteney Cox and Snow Patrol's Johnny McDaid separate after over 10 years together.
Community Harvest receives $5,000 grant from the St. Joseph Community Health Foundation
Community Harvest Food Bank received a $5,000 grant from the St. Joseph Community Health Foundation.
Madonna makes rare reveal of 1 major pop diva she was 'jealous' of
"I was like, 'I'll never be as beautiful as Kylie!'" she said.
Alejandro Davidovich Fokina wins first ATP Tour title in sixth final appearance
Davidovich Fokina had held five championship points before Saturday without winning a title. He only needed one.
Brewers Continue Testing Jacob Misiorowski's Limits
After touching triple digits with a record-shattering 105.5 mph heater, the Milwaukee Brewers flamethrowing ace escaped a bases-loaded jam to prove his elite resilience and Cy Young caliber endurance.
After ousting Bill Cassidy, Donald Trump faces fresh test of his sway with GOP voters in Louisiana’s Senate runoff
Louisiana Republican voters already rejected an incumbent senator who was crossways with President Donald Trump. In a primary runoff on Saturday, they’ll decide whether to follow Trump’s lead in choosing a new nominee.
Video shows suspect shattering windows at North Bay LGBTQ business
The owners of Townhouse Cocktail Lounge say several windows at the business were shattered by the person in the video. Vallejo police are investigating.
Democratic candidate challenging Rep. Lawler on her bid to ‘tear down political silos’
New York U.S. House candidate and combat veteran Cait Conley (D) joins Meet the Press NOW following her primary win. She faces incumbent Republican Rep. Mike Lawler in one of November’s most closely watched races as Democrats try to flip the House.
TLC stage musical “CrazySexyCool” reveals exclusive first look images of T-Boz, Left Eye, and Chilli
The 1990s girl group gets their story told on stage.
Standout transfer edge rusher reportedly off team at SEC school
Was rated as 4-star transfer after entering portal
New Linux pedit COW Exploit Enables Root Access by Poisoning Cached Binaries
CVE-2026-46331 lets local users gain root on affected Linux systems by corrupting page-cache memory through act_pedit.
Ball State Teacher Preparation Programs Earn Top Ratings in Science of Reading Reviews
By Ball State Communications— MUNCIE, Indiana — Ball State University’s elementary education, early childhood education, and special education teacher preparation programs have earned top marks in two reviews focused on how well future educators are prepared to teach reading through evidence-based,
Cascades doubles down on business case for sustainability
The fiber specialist laid its path forward in a 2026-2030 sustainability plan. It’s emphasizing supplier vetting and its capacity to assist customers with their sustainability goals as it continues to strive for widely recyclable packaging.
2026 NHL Mock Draft
Ahead of tonight’s NHL draft, let’s take a stab at how the first round could play out tonight. First, a moment of silence for our near miss last year – when we tried to predict that Kyle Dubas would go ‘off the board’ with a high pick on a WHL center that no one saw […]
Intel’s Chip Business Shows Signs of Life After Years of Struggle
It is the centerpiece of President Trump’s drive to make more chips in the United States, but the company still has a long way to go before it can be called a complete turnaround.
Moore links Maryland primary to Mamdani-backed wins; analysts disagree
Gov. Wes Moore says Maryland’s primary election showed voters rejected the status quo, but political analysts say the results reflect a more complicated picture.
Granger family pledges largest gift in history of UM-Health Sparrow
The Granger family has pledged the largest gift in University of Michigan Health-Sparrow history for a new behavioral health hospital.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Former Steeler says drafting Pat Freiermuth was a mistake
The criticism was voiced on an episode of Cam Heyward’s
Emily Ratajkowski says she rejects the label 'divorced single mom'
Emily Ratajkowski is opening up about resenting the label "divorced single mom" following her split from ex-husband Sebastian Bear-McClard.
Windows 10 support quietly extended until Oct 2027, as users reject Windows 11
Microsoft extends Windows 10 ESU for home users to October 2027, one year longer than planned. Here's the changes, the cost and how to enroll
Supreme Court clears way for Trump administration to revive restrictive immigration policy
The justices, in a 6-3 decision, overturned a lower court order blocking the practice that limited the number of people who could apply for asylum each day.
Senate Republicans reject war powers resolution after Trump-Cassidy clash
The late-night vote came hours after a fractious meeting that included a shouting match with President Donald Trump over some senators’ opposition to the conflict.
Fermented Food: Does Eating Kimchi or Sauerkraut Have Health Benefits?
Researchers are starting to understand how foods like kimchi, yogurt and sauerkraut affect our health.
Under pressure from Trump, Republican-led Senate reverses course on Iran
The chamber rejected a resolution to force Trump to end the war after he criticized Republicans for undermining his administration’s negotiations.
Senate walks back rebuke of Trump over Iran war
One day after adopting a resolution aimed at removing US military forces from the conflict with Iran, the Senate walked back its rebuke of President Donald Trump’s handling of the war, rejecting an attempt to advance a similar war powers measure.
Senate walks back rebuke of Trump over Iran war
One day after adopting a resolution aimed at removing US military forces from the conflict with Iran, the Senate walked back its rebuke of President Donald Trump’s handling of the war, rejecting an attempt to advance a similar war powers measure.
Closed-door outburst turns into victory for Trump’s Iran negotiations
Senate Republicans flipped to reject Democrats' Iran war powers resolution, handing Trump a key win as U.S.-Iran peace deal talks continue on.
Jaguars roster: Where does DeeJay Dallas fit in backfield?
DeeJay Dallas enters training camp looking to carve out a role in the Jaguars' crowded backfield, with special teams likely playing a key part.
Vegas Chamber hosts annual business expo, featuring teen ‘Baby Shark Tank’ competition
Vegas Chamber hosts annual business expo, featuring teen ‘Baby Shark Tank’ competition
Bangor council rejects proposed rules limiting ICE cooperation
One councilor left abruptly in protest during a heated discussion over ICE.
As Blockbusters Loom, Monkey Business at the Supreme Court
An unlikely trio of justices issued a slashing critique of plea bargains that included several references to orangutans.
Rejuvenating politics and delivering on promises of equality and participation: milestone event in Strasbourg
Young people are shaping the New Democratic Pact for Europe
Podcasts are Changing the Doctor-Patient Dynamic. Is That a Good Thing?
The dynamic in the exam room is changing as more people show up ready to talk about what they’ve heard on podcasts.
Fired Navy Admiral Wins Democratic Runoff in South Carolina’s 1st District
Democrats expect Nancy Lacore to run a competitive general election despite the district’s Republican leaning.
Automakers could halt car sales in California without delay in vehicle tracking law
A group representing major automakers warned on Tuesday that car companies may be forced to halt sales of both new and used vehicles in California on July 1 unless the state delays vehicle technology rules that aim to prevent perpetrators of domestic violence from tracking survivors.
Texans ranked among top 10 best offseasons in NFL by CBS Sports
How good was the Houston Texans' offseason? One publication thinks it's top 10 worthy.
'Potentially hazardous conditions' at Palm Bay business cause shelter-in-place
'Potentially hazardous conditions' at Palm Bay business forces evacuations
“Digger” sneak peek reveals Tom Cruise as an over-the-top oil tycoon who can destroy the world
The "comedy of catastrophic proportions" will hit theaters in October.
Amazon Prime Day streaming deal: Score Apple TV for over 50% off
Stream 'Widow's Bay,' 'Pluribus,' 'Shrinking,' and more of our favorite TV shows for cheap.
1 hurt after vehicle hits Dayton business
The crash was reported shortly after 10:30 a.m. on W. Third Street.
Trump’s Private Health Troubles Are Revealed
Aides confessed the 80-year-old president was “beginning to seem old” for the first time.
Should You Invest in the Invesco Leisure and Entertainment ETF (PEJ)?
Sector ETF report for PEJ
Exclusive: Downed US pilot reported seeing Iranian drones swarm in ‘jellyfish’ formation
A US fighter jet pilot rescued by special forces after being shot down over Iran in April described a shocking sight before ejecting from his aircraft: multiple Iranian drones hovering in the air, moving as one, in a formation that resembled a jellyfish, according to four sources familiar with the matter.
Caitlin Clark, DeWanna Bonner altercation leads to five techs, ejection
The Fever's 86-77 win over the Mercury descended into chaos in the fourth quarter, resulting in five technicals and an ejection.
Caitlin Clark, DeWanna Bonner altercation leads to five techs, ejection
The Fever's 86-77 win over the Mercury descended into chaos in the fourth quarter, resulting in five technicals and an ejection.
ANALYSIS: Fear not Britain, the EU doesn't agree on you rejoining either
Brussels heavyweights are clashing over whether Brexit can be reversed and on what terms
Romanian parliament rejects PM nominee, deepening political deadlock
Adrian Veștea's coalition fell short of a parliamentary majority after the far-right AUR withheld support
Video: Opinion | Why Democrats Need a Politics of Joy
The joylessness of metrics-obsessed, achievement-oriented elite culture is eroding the simple joys of living, the novelist Gary Shteyngart argues on “The Ezra Klein Show.” And, he says, this antipathy toward pleasure is a problem for Democrats.
Will New York Swing Further to the Left? Here’s a Preview of Tuesday’s Primaries.
The city’s high-drama, high-spending primaries will offer clues of progressive momentum and Mayor Zohran Mamdani’s influence.
Examining the Eagles’ hidden roster strength entering training camp
The Eagles enter training camp with a hidden roster strength in the secondary, where Quinyon Mitchell, Cooper DeJean, and Riq Woolen headline a deep defensive back group.
UM Health - Sparrow officials break ground on new $60 million facility
The project expands UM Health-Sparrow Lansing's presence along Michigan Avenue while also furthering along the end of the St. Lawrence campus.
Open Door Health Services Appoints Dr. Amelia Clark as Next Chief Executive Officer
By Carolyn Frost— MUNCIE, IN—After an extensive national search, the Board of Directors at Open Door Health Services is pleased to announce Amelia E. Clark, DrPH, as its new chief executive officer and president. Dr. Clark will begin on July 6, succeeding Bryan Ayars, who will retire in mid-July
Science Saru's New 'Ghost In The Shell' Takes Shape In Annecy
At Annecy, the studio detailed its manga-inspired approach, handcrafted production pipeline, and rejection of GenAI tools.
What is there to teach a Kennedy about politics? As Jack Schlossberg has found out, a lot
If multiple polls and the wariness of friends who have been helping him are proven right, Jack Schlossberg is facing not just potential rejection in Tuesday’s primary but the prospect of letting down the Kennedy name and all the people who still get excited about it.
EasyJet rejects £4.7bn takeover offer from US investment firm Castlelake
The airline describes the latest bid approach from Castlelake as "highly opportunistic".
Record-breaking UK heatwave forecast as health warnings issued
London (PA Media/dpa) -The sweltering heat in the United Kingdom could last until at least Thursday, sparking weather warnings and concerns for vulnerable people, the Met Office said on Monday. Foreca...
Celtic move for defenders Smajlovic & Saracchi
Celtic and Olympiacos have had bids of £3.5m for centre-back Zinedin Smajlovic rejected by Sandefjord, who want closer to £4.3m for the 22-year-old. Meanwhile, Celtic are set to intensify talks with Boca Juniors over a permanent deal for Marcelo Saracchi after the 28-year-old left-back was told by head coach Rodolfo Arruabarrena he is not in his plans after his loan to the Scottish champions. Reported Celtic transfer target Soufiane El-Faouzi is poised to sign a new contract with Schalke until 2030 that will hand the 23-year-old midfielder an annual salary of nearly £1m.
Gossip: Jackson hopes to remain at Chelsea
Striker Nicolas Jackson will not push for a move away from Chelsea as he aims to impress new manager Xabi Alonso in pre-season. (Football Insider)
Isaiah Thomas facing pushback on Chris Paul-Spurs take
Isaiah Thomas sparked debates online with his big claim on Sunday. The two-time All-Star guard said that the San Antonio Spurs would’ve won the NBA championship if they still had Chris Paul. “The Point God” signed a one-year, $11 million…
Ewan Mitchell explains 'House of the Dragon' season 3's shocking Aemond-Alicent moment
Ewan Mitchell explains 'House of the Dragon' season 3's shocking Aemond-Alicent moment from the premiere.
Panthers Acquire Brady Tkachuk From Ottawa In Blockbuster Trade
Robbinsdale Entertainment offers free bowling for dads, summer-long Sunday discounts
Families spent Father’s Day at Robbinsdale Entertainment this weekend, where the center offered a special deal letting fathers bowl for free all day
Book lovers rejoice! 'The Five Star Weekend' gets companion podcast with author Elin Hilderbrand
EW can exclusively announce author Elin Hilderbrand will host a companion podcast for Peacock's 'The Five Star Weekend,' an adaptation of her best-selling book starring Jennifer Garner.
Book lovers rejoice! “The Five Star Weekend” gets companion podcast with author Elin Hilderbrand (exclusive)
Jennifer Garner, D'Arcy Carden, Regina Hall, Chloë Sevigny, and Gemma Chan star in Peacock's adaptation of the best-selling novel.
Actor Recalls How His Fling With Anderson Cooper At 25 Inspired Storyline On Hit HBO Show
"When I told [the showrunners] that, they were like, 'Oh, that's a fun story,'" Rannells said.
Father's Day launch for male mental health campaign
ManDown wants to raise funds to create more meeting groups for men to attend in the UK.
US Open payout, purse: How much does each golfer get?
Here's a look at the purse and prize money payouts for the 2026 U.S. Open.
Is Your Vibe ‘High-Signal’ or ‘Anti-Signal’?
Subtle cues are shaping notions of what’s hot and what’s not in the tech world.
Is Your Vibe ‘High-Signal’ or ‘Anti-Signal’?
Subtle cues are shaping notions of what’s hot and what’s not in the tech world.
The Carolina Hurricanes Stanley Cup Parade Was Magnificently Unhinged
A Mikko Rantanen sweater was thrown into the parade path (and stomped on by fans), and three of the featured […]
Sandro Tonali transfer news: Tottenham's £80m bid rejected by Newcastle for Italy midfielder
Roma reject Premier League approaches for wing-back Wesley
Serie A side Roma saw Wesley impress in the 2025/26 campaign and the wing-back is already attracting interest from clubs in England.This isn’t new for the Brazilian, who picked up an injury two week...
Trump says Meloni 'wants to be friends again' after Italy refused to help US amid Iran war
President Donald Trump said Giorgia Meloni did not let the U.S. use Italy's landing strips in its war against Iran and rejected being friends with her.
Opinion | We Need to Keep Funding Weird Science
Science turned a serendipitous finding about lizard venom into one of the most important drugs of the century, but that type of research is getting harder to do.
Disability Groups Fear RFK Jr.’s New Special Education Role
Alienated by Secretary Robert F. Kennedy Jr.’s claims about autism, advocates for disabled students are sounding the alarm about the Trump administration's shifting special education programs to his department.
Video: How a New York Politics Reporter Sets Priorities
Nicholas Fandos explains how he navigates coverage of the primary races this month and what he’s watching in New York politics.
Cottage Cheese Shortages Are Driven by TikTok and ‘Protein-Maxxing’
TikTok and “protein-maxxing” are driving a cottage cheese squeeze that’s left some consumers desperate.
Historical cricket club celebrates bicentenary
The club is the oldest in its county and has a history spanning 200 years.
As temperatures climb, Health officials urges parents to sharpen water safety habits
Dr.Emanuele Maccalli fromKaweah Health shares important information with the community about water safety.As the temperature rises, the concern of drowning al
Judge rejects Biden's attempt to halt release of special counsel inquiry transcripts
U.S. District Judge Dabney Friedrich said in a ruling Friday that the public interest in the material outweighed whatever privacy rights Biden had.